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Microbial communities spanmany orders of magnitude, ranging in scale from hundreds of cells on a single particle of soil to
billions of cells within the lumen of the gastrointestinal tract. Bacterial cells in all habitats are members of densely populated
local environments that facilitate competition between neighboring cells. Accordingly, bacteria require dynamic systems to re-
spond to the competitive challenges and the fluctuations in environmental circumstances that tax their fitness. The assemblage
of bacteria into communities provides an environment where competitive mechanisms are developed into new strategies for sur-
vival. In this minireview, we highlight a number of mechanisms used by bacteria to compete between species. We focus on recent
discoveries that illustrate the dynamic andmultifaceted functions used in bacterial competition and discuss how specific mecha-
nisms provide a foundation for understanding bacterial community development and function.
Microbes compete to survive in naturally mixed communitiesand diverse environments.Microbial communities colonize
niches as different as the surface of our teeth to the soils beneath
our feet. The taxonomic diversity of organisms within these com-
munities is a complex function of differing nutrients, niches, and
interactions between species. In general, the abiotic influences on
communities are identified through analysis of the chemical, spa-
tial, and other relevant parameters that define local environments.
Abiotic factors are varied, affecting microbial growth in many
ways, and can often be manipulated in the laboratory to under-
stand their influence onmicrobial communities. The interactions
between species, on the other hand, are functions of a particular
community and are a challenge to identify and resolve. Some
broad categorization provides guidelines for outcomes expected
during interaction between species. Specifically, when nonneutral
interactions occur between species, they are at times cooperative,
but this appears to be the exception to the rule (1). More com-
monly, competition between species appears to define the inter-
actions that may predominate in microbial communities.
Competition is categorized into two modes, exploitative and
interference (2). Exploitative competition is passive in the sense
that one organism depletes its surroundings of nutrients, thereby
preventing competitors from gaining access to those resources. In
contrast, interference competition invokes antagonistic factors
produced to impede competitors (3). In microbial systems, com-
petition is typically framed in the context of growth limitation or
inhibition due to exploitation and interference. However, while
speciesmay be sensitive or resistant to growth inhibitory activities,
they alsomay engage in antibiotic synthesis, motility, sporulation,
predatory functions, and biofilm formation in response to com-
petition. Although not universal among all bacteria, these physi-
ological changes represent the diversity ofmechanisms to enhance
the competitive fitness of bacterial species equipped with them.
The ability of individual species to employ a spectrum of compet-
itive mechanisms and responses to challenges may be essential to
their survival in communities of diverse organisms, where com-
petitive stress may take many forms. To better understand the
forces that enable bacteria to thrive in communities, we consider
numerous competitive functions that determine the relative fit-
ness of different bacteria within a community.
Direct studies on natural communities, such as those in soils or
plant and animal hosts, are notoriously difficult, because they are
complex and variable. Also, explanting environmental isolates to
the laboratory creates additional complications. For instance,
many organisms do not grow under standard laboratory condi-
tions. Recent technological advances, such as the iChip (4), enable
the growth of many previously uncultured bacteria, but in situ
manipulation of whole bacterial communities remains challeng-
ing. A frequently used approach to study microbial community
interactions is to culture two or more species together under de-
fined conditions. By investigating microbial interactions in de-
fined formats, culture-based studies can provide powerful mech-
anistic insights into competitive functions.
In recent years, competition studies between bacteria have
contributed to a more informed view of the competitive mecha-
nisms used by different species. We focus this minireview on
mechanisms of interference and exploitation competition be-
tween species involving specialized metabolites, enzymes, and
functions associated with the cell envelope, highlighting interac-
tion outcomes that differ from growth inhibition by classical an-
tibiotics. The cell envelope forms the barrier between a bacterial
cell and its surroundings, which include competing bacteria. We
will parse different competitive mechanisms into those that occur
across the envelope due to the exchange of diffusible factors and
those that require contact between cell envelopes, either directly
or via their embedded proteins.
INTERFERENCE AND EXPLOITATION AT A DISTANCE
Specialized metabolites. Competition between species is often
mediated through bioactive metabolites synthesized by competi-
tors. Specialized metabolites (SMs) are molecules produced by
bacteria that are not involved in primary metabolism but are in-
volved in other biological processes.Many specializedmetabolites
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were previously called “secondary” metabolites because their
presence is dispensable under laboratory conditions, and their
production often occurs during the late stages of growth (5).
However, SMs may be essential for some bacteria to persist in the
environment (6) or under competitive stress. In the context of
competitive interactions, SMs of primary interest are those affect-
ing the growth and development of competing bacteria. For in-
stance, antibiotics provide some of the clearest mechanistic in-
sights into chemical interactions between competing species of
bacteria. However, considering their measurable biological activ-
ities at subinhibitory concentrations, even the empirical roles of
antibiotics in nature are subject to debate (7–10). Overall, the
biological functions of SMs are numerous and, arguably, largely
unknown.We will focus, therefore, on several illuminating exam-
ples where bacteria use antibiotics and other SMs in precisely tar-
geted mechanisms that affect competing organisms in ways other
than inhibition of growth. The ability of bacteria to respond dy-
namically to a range of chemical stresses may have profound ef-
fects on their fitness in competitive multispecies communities.
Exploitation competition due to SMs. In some cases, clearly
self-serving functions of SMs indirectly lead to the exploitation of
resources, yielding a competitive advantage. Exploitation compe-
tition occurs when one organism disrupts the growth of its com-
petitors by using a shared limited resource (11). Exploitation often
occurs when one bacterial species alters its external environment
through various metabolic functions and prohibits the growth of
other bacterial species (3). This exploitation can arise from direct
consumption of nutrients, buildup of toxic waste products, or the
activity of SMs. An example of SM-mediated exploitation is found
in siderophores, which are SMs produced for the capture of iron
(12). Iron is essential for cytochromes and iron-sulfur proteins,
and competition for iron is driven by its availability. Siderophores
are one mechanism to chelate external iron, which is then im-
ported as a complex into the producer cells (13). Siderophore
production thus increases the bioavailability of iron and simulta-
neously depletes the supply available to competitors. The signifi-
cance of iron is underscored by the numerous examples of sidero-
phore-mediated competition in different environments, including
competition for colonization of the light organ in Hawaiian
bobtail squid by different strains of Vibrio fischeri (14) and be-
tween the human opportunistic pathogens Staphylococcus aureus
and Pseudomonas aeruginosa (15). Bacteria also acquire iron from
their environment and engage in exploitation competition by us-
ing other iron uptake systems, including transporters (16). How-
ever, because siderophores are extracellular SMs, they are also
subject to piracy by other species, posing a competitive risk to the
producing organism (e.g., see references 17 and 18). These exam-
ples of siderophore-mediated interactions illustrate the potential
complexity of specialized metabolites and exploitative interac-
tions that are probably pervasive in nutrient-limited environ-
ments.
Interference competition due to SMs. (i) Antibiotic activity
without antibiosis. The classic view of antibiotics and other SMs
as weapons has guided their isolation and characterization since
their discovery. In the process of discovery, antibiotic molecules
are isolated from bacterial strains grown in the laboratory and
tested for growth inhibition of target organisms (19). This ap-
proach has been effective for identifying the majority of antibiot-
ics, but it has left gaps in our understanding of the ecological
functions of these molecules. For instance, concentrations of an-
tibiotics sufficient to inhibit growth may be rare in natural envi-
ronments (20, 21). Do antibiotics at lower-than-inhibitory con-
centrations have functions relevant to competitive interactions?
This question has inspired investigation into the effects of subin-
hibitory concentrations of antibiotics on bacteria, where a wide
range of responses have been observed among organisms exposed
to different antibiotics. For example, subinhibitory concentra-
tions of jadomycin B cause Streptomyces coelicolor to prematurely
sporulate and produce a pigmented antibiotic, prodigiosin (22).
Subinhibitory concentrations of kanamycin induce the expression
of type VI secretion genes in P. aeruginosa (23). Numerous other
antibiotics induce global transcriptional responses (reviewed in
depth in reference 24). Cellular stresses from subinhibitory anti-
biotic concentrationsmay trigger these responses as early warning
systems of chemical warfare. Alternatively, the natural functions
of some antibiotics and SMsmay be reflected in the subinhibitory
responses of competitors, independent of inhibitory activity (10).
Clearly delineated mechanisms of concentration-dependent ac-
tivities and responses during competition are needed to under-
stand the roles of antibiotics and other SMs in community dy-
namics.
(ii) Multifunctional metabolites. Bacteria produce many
SMs, representing an enormous chemical diversity with poorly
understood function (20). Although antibiotic activity is themost
common activity ascribed to SMs, many antibiotics also have ef-
fects on bacterial competitors that are independent of growth in-
hibition (see above). There are numerous reports detailing the
effects of SMs on the multicellular development of a bacterial
species. For example, the soil bacterium Pseudomonas protegens
produces 2,4-diacetylphloroglucinol, an SMwith antifungal activ-
ity that is used in biocontrol (25). The cellular differentiation of
Bacillus subtilis is inhibited by 2,4-diacetylphloroglucinol when
cultured with P. protegens (26). In contrast, B. subtilis biofilm for-
mation is stimulated by the antifungal nystatin (27) and by pep-
tide antibiotics (28). Bacillaene is a B. subtilis-produced SM that
was originally identified as an antibiotic inhibitor of protein syn-
thesis (29). Bacillaene also interferes with prodigiosin production
in Streptomyces coelicolor and Streptomyces lividanswithout inhib-
iting growth (30, 31).
Another mechanism for SM interference in competitor devel-
opment is to derail normal signaling processes. For example, some
marine bacteria produce SMs that interfere with quorum sensing
and thus disrupt subsequent downstream processes reliant on
communication between competitor cells (32, 33). One challenge
is to understand the fitness benefits of such modulatory activities
in competitive interactions between bacteria. However, in many
cases, the connection between SMs and the responses they elicit in
competitors is unknown. Model systems using two or more bac-
teria cultured together have been developed to investigate how
SMs and other factors influence competitive fitness under con-
trolled settings.
Model systems of SM-mediated competition between spe-
cies. Multispecies model systems are advantageous because they
open the door to the diversity of competitive functions used by a
single organism, including the production of multiple SMs and
different patterns of response to competitor SMs. Soil bacteria
provide an illustrative example of diverse competitive functions.
Species of Streptomyces are ubiquitous in the soil and renowned
for their capacity to synthesize SMs (34). In addition, Streptomyces
species undergo developmental phases of their life cycle, including
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aerial growth and sporulation, which may be affected by SM ac-
tivity (35). For example, sporulation of some streptomycetes de-
pends upon the peptide SapB, which acts as a surfactant and low-
ers surface tension, enabling aerial hyphae to expand upward (36).
Bacillus subtilis produces its own lipopeptide surfactant, surfactin.
Bacillus subtilis requires surfactin for biofilm development and
some types of motility (27, 37, 38). Intriguingly, surfactin also
antagonizes aerial development of many Streptomyces species (39,
40). Insight into the mechanism arose from S. coelicolor, which
when treated with surfactin was unable to process and secrete
SapB to support aerial growth (41). Compared to antibiotics that
target growth, inhibition of sporulation is a relatively subtle de-
velopmental effect that presumably prevents the spread of Strep-
tomyces. Although B. subtilis does not likely produce multifunc-
tional surfactin explicitly for competition, the inhibition of
Streptomyces development may enhance competitive fitness in
natural environments. Indeed, some species of Streptomyces have
acquired enzymatic resistance to surfactin, consistent with a nat-
ural competitive function. Using imaging mass spectrometry, it
was demonstrated that Streptomyces sp. strain Mg1 hydrolyzes
surfactin (Fig. 1A and B) (40). The enzyme, surfactin hydrolase,
was shown to specifically inactivate surfactin and plipastatin, an-
other lipopeptide produced by B. subtilis (40). Hydrolytic inacti-
vation is a common resistance mechanism for many antibiotics
(42). Analogous to the emergence of new -lactamases, the pro-
duction of surfactin hydrolase and other antibiotic-degrading
enzymes promotes the competitive fitness of their bacterial pro-
ducers, although with surfactin, the selection is against a develop-
mental process.
Competitive culture models enable us to interpret the func-
tions of SMs in new ways that enhance our view of competition
dynamics. Several reports show that SMs provide defense against
otherwise overwhelming forces. For instance, laboratory strains of
B. subtilis are preyed upon by Myxococcus xanthus, but the undo-
mesticated B. subtilis strain NCIB 3610 is resilient (43). Many
domesticated laboratory strains of B. subtilis lack a gene, sfp, re-
quired for the production of several SMs, including bacillaene (44,
45). This defect, which renders domesticatedB. subtilis susceptible
toM. xanthus predation, was subsequently shown to be specific to
the loss of bacillaene production (43) (Fig. 1C and D). Indeed,
exogenous application of bacillaene protected sensitive strains of
B. subtilis and Escherichia coli from predation. Thus, under the
pressure of predation, bacillaene is essential for the defense of B.
subtilis. Intriguingly, this is not the only demonstration of a de-
fensive role for bacillaene. Strains of B. subtilis deficient in bacil-
laene production are also hypersensitive to lysis by linearmycins
produced by Streptomyces sp. Mg1 (46, 47). Bacillaene was origi-
nally discovered as an antibiotic inhibitor of protein synthesis
(29), and its function is dispensable for the growth of B. subtilis.
However, competition studies expand our view of bacillaene to
include essential defensive functions, the precise mechanisms of
which are not known. Nevertheless, examples, such as bacillaene
and surfactin, serve to illustrate that SMs provide diverse and im-
portant competitive functions for the producer organisms.
As seen in examples ranging from antibiotics to siderophores,
SMs have varied and sometimes essential functions in competi-
tion between species.However, aside fromantibiotics, littlemech-
anistic detail is available for the targets and processes affected by
SMs (e.g., see references 32 and 33). The identification of chemi-
callymediatedmechanisms of competition will require continued
exploration of the competitive dynamics between species. An im-
portant consideration is how the SMs operate along with other
entities that mediate interactions between competing species.
Secreted enzymes. In addition to SMs, bacteria secrete en-
zymes that participate in competition. Secreted enzymes that con-
fer antibiotic resistance have a clear competitive benefit (40, 42).
Additionally, bacteria benefit by interfering with the development
of their competitors, e.g., using enzymes to degrade signalingmol-
FIG 1 Mechanisms of bacterial competition. (A and B) Detection of patterns
of SM production and degradation through imaging mass spectrometry. (A)
False-colored extracted ion image showing the distribution of surfactin (blue)
produced by B. subtilis and hydrolyzed surfactin (yellow) resulting from the
activity of surfactin hydrolase secreted by Streptomyces sp. Mg1. (B) The ex-
tracted ion image from panel A overlaid onto a photograph of a culture of B.
subtilis and Streptomyces sp. Mg1 to highlight the localization patterns of each
SM during competition. (C and D) Revealing essential SM functions using
predator-prey interactions. (C) Photograph of M. xanthus spotted onto the
center of awild-typeB. subtilisNCIB3610 colony. The colony ismostly opaque
due to intact viable B. subtilis cells. (D) A mutant B. subtilis strain deficient in
bacillaene production becomes transparent as it is consumed by M. xanthus,
which forms fruiting bodies on the lysed remains of the B. subtilis colony. (E
and F) Structural features of a contact-mediated competitive apparatus. (E)
Cryo-electronmicrographs of a T6SS apparatus inside an intactVibrio cholerae
cell. Scale bar  100 nm. IM, inner membrane; OM, outer membrane. (F)
Comparison of flagellum (F) and T6SS sheath (S) isolated from V. cholerae.
Scale bar 100 nm. Panels C andDwere provided by JohnKirby. Panels E and
F were reproduced with permission from reference 152.
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ecules, like acyl homoserine lactones (48–51). However, surpris-
ingly little is known about how bacteria use secreted enzymes to
kill or inhibit their competitors. The predatory bacteriumM. xan-
thus is a prolific producer of degradative enzymes and encodes in
its genome more than 300 degradative hydrolytic enzymes (52,
53). The functions of many of these enzymes are unknown, but
bacteriolytic activity has been demonstrated for some (54). An
example of competitive enzyme function is found where Staphy-
lococcus epidermidis competes with S. aureus for colonization of
the human nasal cavity (55). Staphylococcus epidermidis secretes a
serine protease, Esp, which inhibits S. aureus biofilm formation
(56). Esp degrades S. aureus biofilms by inactivating autolysins
and preventing the release of DNA that is an essential component
of the biofilm extracellular matrix (57). The presence of Coryne-
bacterium spp. in the nasal cavity is often inversely correlated with
pathogenic Streptococcus pneumoniae (58). Like S. epidermidis,
Corynebacterium accolens also utilizes a secreted enzyme, LipS1, to
interfere with a competitor. LipS1 is a triacylglycerol lipase that
produces oleic acid from the hydrolysis of a human-produced
triglyceride, triolein (59). Oleic acid and other free fatty acids in-
hibit the growth of S. pneumoniae (59, 60). Esp and LipS1 interfere
with bacterial competitors but through fundamentally different
mechanisms. Thus, secreted enzymes may have many active roles
at or near the cell surface of competitors, although this area is in
need of further study.
Extracellular vesicles. Extracellular vesicles are of great inter-
est for both bacterial and eukaryotic interaction processes. Vesi-
cles are capable of vectoring proteins, lipids, nucleic acids, and
small molecules that function in competitive and signaling pro-
cesses (61). Many bacteria produce extracellular vesicles (EVs)
during normal growth. The precise mechanisms of EV biogenesis
and cargo loading are beginning to be identified. Gram-negative
bacteria produce EVs (also called outer membrane vesicles) when
the outer membrane is “pinched,” and the vesicle buds from the
cell surface (62). A second vesicle releasemechanism is reported to
occur within biofilms of P. aeruginosa (63). In this system, pro-
phage-encoded endolysins activate cellular lysis, releasing mem-
brane fragments that form vesicles and permeate the extracellular
space. The problem for Gram-positive bacteria is more compli-
cated due to the lack of an outermembrane, and themechanismof
EV generation is currently unknown, although several models
have been hypothesized (64). After formation, EVs are released
into the environment. When an EV encounters a Gram-negative
cell, the vesicular membrane and the outer membrane fuse, which
delivers the cargo into the recipient’s periplasm (65). Extracellular
vesicles have been observed to adsorb to the cell wall of Gram-
positive bacteria, thereby delivering their contents to target cells
(65).
Extracellular vesicles are used by bacteria for diverse processes,
including biofilm formation (66), carbon storage (67), virulence
(68), and quorum sensing (69). Bacteria also use EVs for defensive
measures against several types of antimicrobial insult. For in-
stance, the EVs of Prochlorococcus adsorb phages (67), and EVs
from P. aeruginosa and S. aureus protect -lactamases from pro-
teolytic degradation (70, 71). Although EVs are often character-
ized for their defensive functions (72), bacteria also use vesicles to
deliver antagonistic agents to competing bacteria. These agents
can be enzymes, such as the peptidoglycan-degrading hydrolases
produced by P. aeruginosa (65) and Lysobacter sp. strain XL1 (73),
or antibiotic SMs, like actinorhodin or prodigiosins found in the
EVs produced by S. coelicolor (74) and S. lividans (75), respec-
tively.
The EVs of M. xanthus are a tour de force in regard to their
competitive potential. The EVs produced by M. xanthus contain
not only 29 predicted hydrolytic enzymes (11 of which were not
found in the outer membrane) but also 16 SMs, including the
myxalamids, which are known antibiotics, and DKxanthene 534
(76). DKxanthene 534 andmyxalamids are polyketide and hybrid
polyketide-peptide molecules, respectively, both having nonpolar
hydrocarbon regions. Consistent with membrane localization,
both molecules are typically extracted from cell pellets and have
low abundance in supernatants (77, 78). These characteristics
highlight an important function of EVs to facilitate the transfer of
hydrophobic molecules, including antibiotics, across aqueous en-
vironments (69).
Extracellular vesicles also intersect with SMs in intriguing pat-
terns that may affect competition between bacteria. Recently, it
was shown that B. subtilis disrupts its own EVs by secreting sur-
factin (79). The targeted lysis of EVs by surfactin may serve as a
defensive mechanism against antibiotic-laden vesicles produced
by competing organisms or as an offensive tool to prevent nonpo-
lar signalingmolecules, including quorum sensors, from reaching
their intended targets. Extending on overlapping functions, bac-
teria reportedly become reversibly resistant to antibiotics when
they swarm (80). In B. subtilis, swarming motility requires surfac-
tin (81, 82). As an intriguing hypothesis for niche exploration, B.
subtilis might produce surfactin not only to promote its move-
ment over surfaces but also as a defense mechanism against EVs
produced by other organisms.
CONTACT-MEDIATED COMPETITION
Different species of bacteria physically interact at high cell densi-
ties in ways that promote information exchange, such as plasmid
conjugation, or through competitive interaction mechanisms.
Some competitive functions appear to have evolved to function
specifically in close proximity. In particular, bacteria use mem-
brane- and cell envelope-embedded functions that are outwardly
directed toward competitors. Such mechanisms are likely to be
important for survival under crowded conditions through both
their inhibitory functions and their contributions to community
structure.
Contact-dependent inhibition.As a specificmechanismof in-
terference competition, contact-dependent inhibition (CDI) de-
scribes a membrane protein that operates as a delivery system for
a cellular toxin. The prototypical CDI systemwas first described in
uropathogenic E. coli EC93 and consists of three components,
CdiA, CdiB, and CdiI (83). CdiA and CdiB are homologous to the
two-partner secretion system proteins TpsA and TpsB, respec-
tively. In two-partner secretion systems, the secreted substrate
TpsA is translocated across the outer membrane through its cog-
nate beta-barrel protein TpsB (84). Likewise, in CDI systems, the
toxin CdiA is attached to CdiB, which is an outermembrane beta-
barrel protein that extends away from the cell. This arrangement
leads to CDI being referred to as a “toxin on a stick” (85). CdiI
provides the producing cell with immunity toward its own toxin
by specifically binding to CdiA and inhibiting its activity (86).
When a CDI-producing cell (CDI) makes direct contact with a
susceptible target cell, its CdiA toxinmakes contact with the target
cell’s outer membrane protein BamA (87). The CdiA protein is
then deposited onto the target cell surface and undergoes self-
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cleavage, which transports the carboxy-terminal (CT) portion of
CdiA into the periplasm (88).ManyCdiA toxins are nucleases and
require entry into the cytoplasm to exert their effects (86). Trans-
location of the toxin into cytoplasm requires the proton motive
force (89) and interaction with toxin-specific inner membrane
protein receptors (90). The requirement for amembrane receptor
protein on target cells limits CDI to a narrower range of specificity
compared to diffusible agents, like antibiotics. This specificity is
due to variability in extracellular loops 6 and 7 of BamA, which
form the CdiA-CT-binding site (91). Due to the narrower target
range, it has been speculated that CDI systems are a means to
inhibit closely related species. This would allow CDI bacteria to
inhibit other bacteria that aremore likely in direct competition for
the same or very similar ecological niches (85).
Biofilms are community structures that form as a result of the
concerted effort betweenmany cells. The conditions within a bio-
film are inherently stressful to cells. Resources, including nutri-
ents, oxygen, and physical space, are limiting (92). These condi-
tions breed competition between cells within the biofilm and
provide strong selection for competition. For example, growth
within a biofilm selects for bacteria that engage in exploitation
competition by preferentially occupying biofilm surfaces and
gaining access to oxygen (93). Biofilm growth has also selected for
cells that are able to engage in inference competition with their
neighbors. Burkholderia thailandensis illustrates the utility of CDI
functions for promoting competitive success in a biofilm. Disrup-
tion of the CDI system (CDI) of B. thailandensis both sensitizes
cells to CDI from isogenic siblings and abolishes biofilm forma-
tion (94). Both functions are tied to BcpA (homologous to CdiA),
but the biofilm functions are independent of CDI activity (95).
These observations suggest that CDI systems help ensure a com-
petitive advantage by supporting biofilm formation while exclud-
ing competitors. CDI-dependent cell adhesion and defects in bio-
film production for CDI strains have also been reported in E. coli
(96) and P. aeruginosa (97), further solidifying the link between
CDI and biofilm development.
Aside from the costs of biofilm formation and the cellular chal-
lenges within a biofilm, these structures serve to protect bacteria
from various external stresses (98, 99). For instance, bacteria have
evolved mechanisms, including CDI, to competitively exclude
nonsibling cells from biofilms (100). Developing biofilms contain
three-dimensional structures called “pillars” for B. thailandensis
(101). These structures extend outwards from the biofilm attach-
ment site, providing cells within the pillars better access to oxygen
and nutrients than the cells in the biofilm substratum (92). The
CDI system of B. thailandensis excludes CDI-sensitive cells from
developing pillars (101). Cells that produce the same CDI system,
presumably siblings, are not killed by CDI due to their cognate
immunity genes. This selective killing by CDI provides a kin dis-
crimination mechanism for B. thailandensis biofilms and likely
protects the biofilm from invaders. Taken together, the CDI func-
tions of B. thailandensis demonstrate important competitive ad-
vantages that arise in close cellular proximity through the direct
inhibition of competitors and through the construction of defen-
sive biofilm structures.
Type VI secretion systems. The type VI secretion system
(T6SS) was originally identified as a virulence factor produced by
V. cholerae against amoebae and macrophages (102). Subse-
quently, genes encoding T6SS were found in roughly one-quarter
of Proteobacteria with sequenced genomes (103), including but
not limited to opportunistic pathogens, such asAcinetobacter bau-
mannii (104) and Serratia marcescens (105). The observation that
many of the identified T6SS had no apparent effect on eukaryotic
cells and that T6SS gene clusters occurred in nonpathogenic bac-
teria prompted investigation into potential antibacterial activities
(105, 106).
The T6SS ofGram-negative bacteria has emerged as a powerful
weapon in close-quarters interference competition between bac-
teria. The basic mechanism of function for the T6SS is to inject
toxic effector molecules directly into the cytoplasm of target cells.
Structurally and functionally, the T6SS apparatus is homologous
to bacteriophage contractile tails (107). The T6SS apparatus is a
cylindrical spiked-tipped inner tube that is surrounded by a
sheath and anchored to the inner membrane (Fig. 1E and F).
When the cell is in physical contact with its target, the sheath
contracts, and the inner tube is propelled outward and punctures
themembrane of a target cell using its spiked tip.Within the target
cell, the spike disassociates from the tube, and the toxic effectors
are delivered. Common effectors characterized thus far include
phospholipases (108–110), peptidoglycan hydrolases (111–113),
and nucleases (114, 115).
In addition to T6SS being an effective delivery system for toxic
payloads, one example demonstrates that the sharpened spike of
the T6SS is a potent weapon even in the absence of toxic effectors.
Using its TagQRST-PpkA-Fha1-PppA sensing system, P. aerugi-
nosa detects cell envelope damage caused by the T6SS of other
bacteria (116). This detection or “danger sensing” allows the cell
to mount a response against its antagonist and minimize future
damage to the cell or its siblings (117). In the case of P. aeruginosa,
the cell retaliates against T6SS-mediated attacks, directing its own
T6SS in the same direction as the initial attack in a behavior called
“dueling” (118). Duels damage target cells and can cause mem-
brane blebbing, plasmolysis, and even lysis. Strains of P. aerugi-
nosa that are deficient in the production of all known T6SS effec-
tors still retaliate against T6SS-mediated attacks and engage in
dueling with effective killing activity (116). If P. aeruginosa cells
lose their duels and are lysed by competitors, they release diffus-
ible danger signals that stimulate T6SS activity and promote the
survival of siblings (119).
Like CDI, the T6SS killing mechanism also functions to favor
siblings in multicellular activities. Strains of Proteus sort self from
nonself inmobilemulticellular swarms. This kin discrimination is
observed as cell-free zones between swarms called Dienes lines
(named for their discoverer Louis Dienes) on agar surfaces. In
these zones, opposing swarms of Proteus mirabilis do not inter-
mingle. The establishment of Dienes line formation was found to
be due to the T6SS (120). At the intersection between opposing
swarms, P. mirabilis use their T6SS to kill and in turn are killed by
the T6SS of competitors, creating a demilitarized zone (DMZ)
where the Dienes lines exist between mobile populations. As with
B. thailandensis, strains join the beneficial swarm when they are
not killed by the T6SS. An added benefit of this kin discrimination
arises because swarming provides increased resistance to antibiot-
ics (80). Thus, entry into the swarm promotes competitive fitness
of bacteria by excluding unrelated cells and by enhancing defense
against antibiotics. Similar boundary formation has also been re-
ported forM. xanthus (121) and B. subtilis (122). The observation
of discrimination in B. subtilis demonstrates that CDI and T6SS
are not the only mechanisms that bacteria use for kin discrimina-
tion, as B. subtilis does not produce CDI or T6SS. The question
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remains whether B. subtilis demarcates Dienes lines through a
contact-dependent or -independent mechanism, although evi-
dence suggests that combinatorial mechanisms are used (123).
The CDI and T6SS are analogous in that a toxin is delivered
directly to a target cell. However, like many antibiotics, these tox-
ins are typically soluble molecules. How then, are insoluble effec-
tors delivered? In one case, the T6SS toxin Tse6, produced by P.
aeruginosa, contains transmembrane domains that are shielded
from the aqueous environment by an associated chaperone. The
chaperone, EagT6, protects Tse6 until delivery into the target’s
periplasm (124). This example appears to be the exception, where
the majority of membrane-associated effectors lack a chaperone
or other clear vectoring mechanism. As described previously, ex-
tracellular vesicles are another mechanism for the delivery of oth-
erwise insoluble cargo.
Outer membrane exchange. In addition to CDI, T6SS, and
EVs, Gram-negative bacteria appear to use the outer membrane
itself as an effective delivery system for otherwise insoluble toxins.
Outer membrane exchange (OME) for Myxobacteria, for exam-
ple, is a contact-dependent mechanism for cells to share mem-
brane components, including phospholipids and insoluble lipo-
proteins, with other cells (125). OME has been demonstrated to
extracellularly complement mutants deficient in the production
of particular outer membrane products. For example, via OME,
the gliding motility of nonmotile M. xanthus mutants is stimu-
lated when mutant cells are mixed with wild-type cells (126).
OME is also intertwined with colony swarming and sporulation
(126). Furthermore, a recent report implicates OME as a powerful
defensive mechanism to dilute membrane damage over a popula-
tion of cells (127).
OME requires the production of an outer membrane protein
complex, TraAB, in both the donor and recipient cell (126).
TraAB appears to be the only component necessary to mediate
OME (128) and, similarly to the BamA receptor in CDI systems,
TraAB contains a polymorphic domain that limits OME to a nar-
row range of related targets (129). Given the functional similari-
ties to CDI systems and the potential of OME to directly deliver
toxic effectors into the envelope of target bacteria, it is not surpris-
ing that Myxobacteria use OME to mediate competition and en-
gage in kin recognition. Motile cells ofM. xanthus are killed when
cultured with their nonmotile siblings. Killing is dependent upon
the presence of TraA in the target motile cell and a polyploid
prophage in the killer nonmotile sibling (130). Currently, the ef-
fector delivered by OME is not known, but it is likely produced
from a toxin-antitoxin module encoded on the prophage (130).
No further examples of OME-mediated competition have been
reported thus far. However, as with EVs, new studies will likely
uncover fascinating roles for these membrane-derived strategies
in bacterial competition.
CONCLUSIONS
Bacteria use competitive mechanisms that are nearly as diverse as
the competitors they encounter (Fig. 2). Inherent in each compet-
itive strategy are advantages and disadvantages.When bacteria use
secreted effectors, like antibiotics, enzymes, or vesicles, they are
able to compete while minimizing the risks of direct damage dur-
ing contact-mediated competition.Once a cell exports its compet-
itive molecules across its envelope, those molecules are subject to
diffusion, which diminishes their inhibitory effect on competitors
at a distance. However, many of these metabolically expensive
products operate between inactive and inhibitory concentrations
and may act as chemical cues for competitors (131). Exposure to
subinhibitory antibiotic concentrations can induce resistant states
(132–134), select for resistant competitors (135), stimulate bio-
film formation (136–138), and stimulate motility (139). The acti-
vation of a resistant state allows a competitor unrestricted access
into a previously protected niche. If potential prey senses a cue and
escapes predation, the producer loses nutrients in the form of that
lysed cell. Thus, if a competitor senses a cue, the producer may
suffer the consequences for competitive fitness. However, it is also
important to note that our current understanding of the response
to subinhibitory concentrations of antibiotics and other SMs in
the context of bacterial communities is limited and requires fur-
ther investigation. The direct delivery of toxins into a target cell by
CDI or T6SS circumvents diffusion and the potential costs of sub-
inhibitory antibiotic concentrations. The trade-off is that contact-
mediated competition puts a cell in direct contact with its com-
petitor and allows the risk of retaliation, such as in the dueling
response (116), or from high concentrations of diffusible SMs.
We have emphasized the differences between competitive
mechanisms that are contact mediated and those that occur at a
distance. However, bacteria are not mutually exclusive in the sys-
tems they employ. For example, Pseudomonas species use T6SS
but are also prolific producers of SMs, including antibiotics and
siderophores (140). Bacteria also use direct contact to deliver se-
creted factors at high local concentration. Predatory Bdellovibrio
species physically collide with target cells, pierce their cell enve-
lope, and digest their prey from within using an impressive cock-
tail of secreted enzymes that includes nucleases and peptidoglycan
hydrolases (141, 142). The differences between contact-mediated
and at-a-distance approaches may reflect how bacteria use both
systems in competition. A cell producing secreted molecules, like
antibiotics, creates a chemical or enzymatic protective shell
around itself. Within this shell, the cell is also able to simultane-
ously engage in exploitative competition via its exclusive access to
nearby nutrients. The spectrum of inhibitory activities, in concert
with small size, low charge, and ease of entrance into target cells
(143, 144), places antibiotics at the foundation of such protective
chemical shells. However, if a competitor breaches the defenses,
the delivery of toxic effectors by CDI or T6SS directly into the
target may stop the invasion. A remarkable balance of antibiotic
resistance and contact-dependent mechanisms has been shown
with A. baumannii (145). Several multidrug-resistant A. bauman-
nii strains carry a plasmid that provides antibiotic resistance while
also inhibiting the expression of T6SS systems. However, the plas-
mid is unstable, and loss of the plasmid provides a mechanism to
activate T6SS at the cost of losing antibiotic resistance in some
cells. The net result is a population with shared functions in com-
petitive fitness through defense and through close-quarters exclu-
sion of competitors. Perhaps contact-mediated mechanisms, like
CDI, T6SS, or OME, are needed to selectively inhibit closely re-
lated competitors with the capacity to pass unharmed across a
chemical defensive barrier (91, 129, 145).
Culture-based studies have revealed many mechanistic details
of bacterial competition. However, we note thatmany of the stud-
ies highlighted in thisminireviewused simple small-scale bacterial
communities withminimal mixing. To gain a deeper understand-
ing of bacterial competition in natural communities, systems are
needed that combine the use of multiple approaches and contain
expanded knowledge of diverse competitive mechanisms. Al-
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though beyond the scope of this minireview, mathematical mod-
eling is a powerful approach to understand how bacterial commu-
nities are formed and maintained (e.g., see references 146 and
147). Mathematical approaches stand to become more powerful
as they incorporate diverse competitive outcomes in addition to
killing or survival. For instance, what effects does T6SS-mediated
retaliation have in a modeled competition? How does SM-medi-
ated developmental inhibition affect a community? What are the
consequences of exposure for cells outside the inhibitory ranges of
SMs? Using controlled experiments in the laboratory, new mech-
anistic details of competition are being identified, despite limita-
tions to our understanding of these mechanisms in natural envi-
ronments. The genomes of many antibiotic-producing bacteria
contain silent SM gene clusters that are not expressed under lab-
oratory conditions (148). Likewise, many studies with CDI and
T6SS require artificial expression conditions (149, 150). These
obstacles are a central focus of current efforts to understand
competitive mechanisms. Meanwhile, models that better
mimic the native environment are being developed to provide
a clearer view of bacterial interactions under natural condi-
tions (e.g., see references 86, 115, and 151) The examples above
and many more innovative studies are expanding our views of
the interactive interfaces between two bacterial species. The
emerging challenge is to build these interfaces into networks,
which will represent the many facets of competition within
microbial communities.
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FIG 2 Summary of mechanisms used in bacterial competition. (A) Contact-mediated mechanisms involve either direct contact between cell envelopes (OME)
or are facilitated by protein complexes (CDI and T6SS). In the case of CDI and T6SS, toxic effectors (square or wedged circle) are delivered into the target cell.
(B) Bacteria compete at a distance using SMs (examples shown are bacillaene and streptomycin), secreted enzymes, and extracellular vesicles. CDI, contact-
dependent inhibition; EVs, extracellular vesicles; M, membrane; MT, target cell membrane; IM, inner membrane; OM, outer membrane; PG, peptidoglycan;
T6SS, type VI secretion system.
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